Fractyl Health, Inc.
NASDAQGUTS just delivered its first positive earnings surprise in recent memory — and then shorts started creeping back in. Fractyl Health posted Q1 EPS of $0.06 against a consensus estimate of -$0.16, a rare beat for a pre-revenue biotech still burning cash. The stock closed at $0.734 on May 12, up 6% on the week despite a 4.6% pullback on the day after results. The one-month move is…
GUTS short interest plummets 21.9% in one week to 1.55% of float, down 62.3% from a month ago. Stock rises 7.9% weekly despite declining short positioning.
Snapshot as of 11 Aug 2026
GUTS just delivered its first positive earnings surprise in recent memory — and then shorts started creeping back in. Fractyl Health posted Q1 EPS of $0.06 against a consensus estimate of -$0.16, a rare beat for a…
GUTS heads into its post-earnings session with a fresh EPS beat and a clinical story that is sharpening, even as the stock trades well below where most analysts think it belongs. The Q1 result was the clearest positive…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GUTS — free to start on ORTEX.
Sign up for free →Open GUTS on ORTEX